The latest closing stock price for Context Therapeutics as of June 13, 2025 is 0.63.
An investor who bought $1,000 worth of Context Therapeutics stock at the IPO in 2021 would have $-877 today, roughly -1 times their original investment - a -40.73% compound annual growth rate over 4 years.
The all-time high Context Therapeutics stock closing price was 7.45 on October 25, 2021.
The Context Therapeutics 52-week high stock price is 2.75, which is 336.5% above the current share price.
The Context Therapeutics 52-week low stock price is 0.49, which is 22.2% below the current share price.
The average Context Therapeutics stock price for the last 52 weeks is 1.45.
An investor who bought $1,000 worth of Context Therapeutics stock at the IPO in 2021 would have $-877 today, roughly -1 times their original investment - a -40.73% compound annual growth rate over 4 years.
The all-time high Context Therapeutics stock closing price was 7.45 on October 25, 2021.
The Context Therapeutics 52-week high stock price is 2.75, which is 336.5% above the current share price.
The Context Therapeutics 52-week low stock price is 0.49, which is 22.2% below the current share price.
The average Context Therapeutics stock price for the last 52 weeks is 1.45.